Citations

Clear

1820 citation(s) found for "Israel, E".

Impact of ATS Resident Boot Camp on Faculty and Fellows who Teach
Bateman, Marjorie , Maximous, S. , Nelson, Darlene R. , Lee, May M. , Drake, Matthew G. , Short, Briana, Quaney, Rachel, Soffler, Morgan , Matta, Maroun, Drake, Matthew G

Mayo Clinic

ATS Scholar | February 2, 2024 | Volume: 5 | Issue: 2 | Pages: 247-253

10.34197/ats-scholar.2023-0105br | PMID 38957496 Get It

Protein–Protein interactive networks identified in bronchoalveolar lavage of severe compared to nonsevere asthma
Hastie, Annette T. , Bishop, Andrew C. , Bleecker, Eugene R. , Denlinger, Loren C. , Erzurum, Serpil C. , Fahy, John V. , Israel, Elliot , Mauger, David T. , Meyers, Deborah A. , Moore, Wendy C. , Ortega, Victor E. , Peters, Stephen P. , Wenzel, Sally E. , Steele, Chad , Wenzel, Sally E , Khan, Mohammad Sharif , Castro, Mario , Levy, Bruce David , Wenzel, Sally E.

Mayo Clinic

Clinical & Experimental Allergy | January 23, 2024 | Volume: 54 | Issue: 4 | Pages: 265-277

10.1111/cea.14447 | PMID 38253462 Get It

AbstractIntroductionPrevious bronchoalveolar lavage fluid (BALF) proteomic analysis has evaluated limited numbers of subjects for only a few proteins of interest, which may differ between asthma and normal controls. Our objective was to examine a more comprehensive inflammatory biomarker panel in quantitative proteomic analysis for a large asthma cohort to identify molecular phenotypes distinguishing severe from nonsevere asthma.MethodsBronchoalveolar lavage fluid from 48 severe and 77 nonsevere adult asthma subjects were assessed for 75 inflammatory proteins, normalized to BALF total protein concentration. Validation of BALF differences was sought through equivalent protein analysis of autologous sputum. Subjects' data, stratified by asthma severity, were analysed by standard statistical tests, principal component analysis and 5 machine learning algorithms.ResultsThe severe group had lower lung function and greater health care utilization. Significantly increased BALF proteins for severe asthma compared to nonsevere asthma were fibroblast growth factor 2 (FGF2), TGFα, IL1Ra, IL2, IL4, CCL8, CCL13 and CXCL7 and significantly decreased were platelet‐derived growth factor a‐a dimer (PDGFaa), vascular endothelial growth factor (VEGF), interleukin 5 (IL5), CCL17, CCL22, CXCL9 and CXCL10. Four protein differences were replicated in sputum. FGF2, PDGFaa and CXCL7 were independently identified by 5 machine learning algorithms as the most important variables for discriminating severe and nonsevere asthma. Increased and decreased proteins identified for the severe cluster showed significant protein–protein interactions for chemokine and cytokine signalling, growth factor activity, and eosinophil and neutrophil chemotaxis differing between subjects with severe and nonsevere asthma.ConclusionThese inflammatory protein results confirm altered airway remodelling and cytokine/chemokine activity recruiting leukocytes into the airways of severe compared to nonsevere asthma as important processes even in stable status.
Identification of Glandular (Acinar)/Tubule Formation in Invasive Carcinoma of the Breast: A Study to Determine Concordance Using the World Health Organization Definition
Lo, Yungtai , Lester, Susan C. , Lanjewar, Sonali, Laurini, Javier A., Patel, Ami , Bhattarai, Ava, Ustun, Berrin , Harmon, Bryan, Kleer, Celina G. , Ross, Dara S. , Amin, Ali , Wang, Yihong , Bradley, Robert, Turashvili, Gulisa , Zeng, Jennifer , Baum, Jordan , Hakima, Laleh , Harigopal, Malini, Shin, Sandra J. , Abbott, Sara, Jaffer, Shabnam , Badve, Sunil Shankar, Khoury, Thaer , D’Alfonso, Timothy M. , Collins, Victoria , Towne, William S. , Gan, Yujun, Flieder, Andrea, Aldrees, Rana, Ngo, Marie-Hélène , Edema, Ukuemi, Sapna, Fnu , Schnitt, Stuart J. , Fineberg, Susan , Komforti, Miglena, Wang, Yihong , Turashvili, Gulisa , Ellis, Ian O. , Singh, Kamaljeet , Komforti, Miglena K. , Badve, Sunil , Ginter, Paula S. , Nassar, Aziza , Şahin, Ayşegül A.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | January 20, 2024 | Volume: 148 | Issue: 10 | Pages: 1119-1125

10.5858/arpa.2023-0163-oa | PMID 38244086 Get It

Context.— The Nottingham Grading System (NGS) developed by Elston and Ellis is used to grade invasive breast cancer (IBC). Glandular (acinar)/tubule formation is a component of NGS. Objective.— To investigate the ability of pathologists to identify individual structures that should be classified as glandular (acinar)/tubule formation. Design.— A total of 58 hematoxylin-eosin photographic images of IBC with 1 structure circled were classified as tubules (41 cases) or nontubules (17 cases) by Professor Ellis. Images were sent as a PowerPoint (Microsoft) file to breast pathologists, who were provided with the World Health Organization definition of a tubule and asked to determine if a circled structure represented a tubule. Results.— Among 35 pathologists, the κ statistic for assessing agreement in evaluating the 58 images was 0.324 (95% CI, 0.314–0.335). The median concordance rate between a participating pathologist and Professor Ellis was 94.1% for evaluating 17 nontubule cases and 53.7% for 41 tubule cases. A total of 41% of the tubule cases were classified correctly by less than 50% of pathologists. Structures classified as tubules by Professor Ellis but often not recognized as tubules by pathologists included glands with complex architecture, mucinous carcinoma, and the “inverted tubule” pattern of micropapillary carcinoma. A total of 80% of participants reported that they did not have clarity on what represented a tubule. Conclusions.— We identified structures that should be included as tubules but that were not readily identified by pathologists. Greater concordance for identification of tubules might be obtained by providing more detailed images and descriptions of the types of structures included as tubules.
Public Health Informatics and the Perioperative Physician: Looking to the Future
Gabriel, Rodney A. , Howell, Stephen, Tan, Jonathan M. , O’Reilly-Shah, Vikas N. , Poterack, Karl A. , Rothman, Brian , Poterack, Karl, Mudumbai, Seshadri C. , Howell, Stephen, Freundlich, Robert E. , Kendale, Samir M.

Mayo Clinic

Anesthesia & Analgesia | January 12, 2024 | Volume: 138 | Issue: 2 | Pages: 253-272

10.1213/ane.0000000000006649 | PMID 38215706 Get It

The role of informatics in public health has increased over the past few decades, and the coronavirus disease 2019 (COVID-19) pandemic has underscored the critical importance of aggregated, multicenter, high-quality, near-real-time data to inform decision-making by physicians, hospital systems, and governments. Given the impact of the pandemic on perioperative and critical care services (eg, elective procedure delays; information sharing related to interventions in critically ill patients; regional bed-management under crisis conditions), anesthesiologists must recognize and advocate for improved informatic frameworks in their local environments. Most anesthesiologists receive little formal training in public health informatics (PHI) during clinical residency or through continuing medical education. The COVID-19 pandemic demonstrated that this knowledge gap represents a missed opportunity for our specialty to participate in informatics-related, public health-oriented clinical care and policy decision-making. This article briefly outlines the background of PHI, its relevance to perioperative care, and conceives intersections with PHI that could evolve over the next quarter century.
The Delphi Delirium Management Algorithms. A practical tool for clinicians, the result of a modified Delphi expert consensus approach.
Ottens, Thomas H. , Hermes, Carsten , Page, Valérie , Oldham, Mark , Arora, Rakesh C. , Bienvenu, O. Joseph , Boogaard, Mark van den , Caplan, Gideon A. , Hansen, Hans-Christian , Inouye, Sharon K. , Kamholz, Barbara, Maas, Matthew B. , MacLullich, Alasdair M. J. , Negro, Alessandra , Neufeld, Karin J. , Nydahl, Peter , Radtke, Finn M. , Raedt, Sylvie De , Rosenthal, Lisa , Vardy, Emma , Slooter, Arjen J. C. , Arora, Rakesh , van den Boogaard, Mark , Caplan, Gideon , Friedrich, Michaela-Elena , Hanison, James , Hansen, Hans-Christian , Inouye, Sharon K , Kotfis, Katarzyna , MacLullich, Alasdair M J , Marcantonio, Edward R , van Munster, Barbara C , Müller-Werdan, Ursula , Nydahl, Peter , Oh, Esther S , Pandharipande, Pratik , Radtke, Finn M , Raedt, Sylvie De , Spies, Claudia D , Vardy, Emma R L C , Wijdicks, Eelco Fm , Slooter, Arjen J C , Devlin, John W. , Kotfis, Katarzyna , Marcantonio, Edward R. , Morandi, Alessandro , Rosenthal, Lisa J., Sanders, Robert D. , Spies, Claudia , Wijdicks, Eelco F. M.

Mayo Clinic

Delirium | January 12, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.56392/001c.90652 | PMID 38348284 Get It

Delirium is common in hospitalised patients, and there is currently no specific treatment. Identifying and treating underlying somatic causes of delirium is the first priority once delirium is diagnosed. Several international guidelines provide clinicians with an evidence-based approach to screening, diagnosis and symptomatic treatment. However, current guidelines do not offer a structured approach to identification of underlying causes. A panel of 37 internationally recognised delirium experts from diverse medical backgrounds worked together in a modified Delphi approach via an online platform. Consensus was reached after five voting rounds. The final product of this project is a set of three delirium management algorithms (the Delirium Delphi Algorithms), one for ward patients, one for patients after cardiac surgery and one for patients in the intensive care unit.
Lung Cancer in Ever- and Never-Smokers: Findings from Multi-Population GWAS Studies
Li, Yafang , Xiao, Xiangjun , Li, Jianrong , Han, Younghun , Cheng, Chao , Fernandes, Gail , Slewitzke, Shannon E. , Rosenberg, Susan M. , Zhu, Meng , Byun, Jinyoung , McKay, James , Lam, Stephen , Chen, Chu , Bojesen, Stig E. , Landi, Maria Teresa , Risch, Angela , Wichmann, H-Erich , Goodman, Gary E. , Field, John K. , Shete, Sanjay , Liu, Geoffrey , Andrew, Angeline S. , Grankvist, Kjell , Johansson, Mikael , Caporaso, Neil E. , Aldrich, Melinda C. , Schwartz, Ann G. , Gorlov, Ivan , Purrington, Kristen S. , Liu, Yanhong , Mandal, Diptasri , Gaba, Colette , Brennan, Paul , Xia, Jun , Fernandes, Gail F , Bossé, Yohan , McKay, James , Albanes, Demetrius , Lam, Stephen , Tardón, Adonina , Chen, Chu , Bojesen, Stig E , Landi, Maria T , Johansson, Mattias , Risch, Angela , Bickeböller, Heike , Wichmann, H-Erich , Christiani, David C. , Rennert, Gad , Arnold, Susanne M , Goodman, Gary E , Field, John K , Davies, Michael P A , Shete, Sanjay , Marchand, Loïc Le , Liu, Geoffrey , Hung, Rayjean J , Andrew, Angeline S , Kiemeney, Lambertus A , Sun, Ryan , Zienolddiny, Shanbeh , Grankvist, Kjell , Johansson, Mikael , Caporaso, Neil E , Cox, Angela , Hong, Yun‐Chul , Lazarus, Philip J. , Schabath, Matthew B , Aldrich, Melinda C , Schwartz, Ann G , Gorlov, Ivan , Purrington, Kristen S , Yang, Ping , Liu, Yanhong , Wilson, Richard K , Pinney, Susan M , Mandal, Diptasri , Willey, James C , Brennan, Paul , Xia, Jun , Shen, Hongbing , Amos, Christopher I , Han, Younghun , Cheng, Chao , Byun, Jinyoung , Bossé, Yohan , Albanes, Demetrius , Tardón, Adonina , Johansson, Mattias , Bickeböller, Heike , Rennert, Gad , Arnold, Susanne M. , Davies, Michael P.A. , Marchand, Loı̈c Le , Hung, Rayjean J. , Kiemeney, Lambertus A. , Zienolddiny, Shanbeh , Cox, Angela , Schabath, Matthew B. , Yang, Ping , Bailey‐Wilson, Joan E. , Pinney, Susan M. , Willey, James C. , Shen, Hongbing , Amos, Christopher I.

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | January 5, 2024 | Volume: 33 | Issue: 3 | Pages: 389-399

10.1158/1055-9965.epi-23-0613 | PMID 38180474 Get It

Abstract Background: Clinical, molecular, and genetic epidemiology studies displayed remarkable differences between ever- and never-smoking lung cancer. Methods: We conducted a stratified multi-population (European, East Asian, and African descent) association study on 44,823 ever-smokers and 20,074 never-smokers to identify novel variants that were missed in the non-stratified analysis. Functional analysis including expression quantitative trait loci (eQTL) colocalization and DNA damage assays, and annotation studies were conducted to evaluate the functional roles of the variants. We further evaluated the impact of smoking quantity on lung cancer risk for the variants associated with ever-smoking lung cancer. Results: Five novel independent loci, GABRA4, intergenic region 12q24.33, LRRC4C, LINC01088, and LCNL1 were identified with the association at two or three populations (P < 5 × 10−8). Further functional analysis provided multiple lines of evidence suggesting the variants affect lung cancer risk through excessive DNA damage (GABRA4) or cis-regulation of gene expression (LCNL1). The risk of variants from 12 independent regions, including the well-known CHRNA5, associated with ever-smoking lung cancer was evaluated for never-smokers, light-smokers (packyear ≤ 20), and moderate-to-heavy-smokers (packyear > 20). Different risk patterns were observed for the variants among the different groups by smoking behavior. Conclusions: We identified novel variants associated with lung cancer in only ever- or never-smoking groups that were missed by prior main-effect association studies. Impact: Our study highlights the genetic heterogeneity between ever- and never-smoking lung cancer and provides etiologic insights into the complicated genetic architecture of this deadly cancer.
Characteristics and Clinical Outcomes of Vaccine-Eligible US Children Under-5 Years Hospitalized for Acute COVID-19 in a National Network
Zambrano, Laura D. , Newhams, Margaret M. , Fleming‐Dutra, Katherine E. , Halasa, Natasha , Wu, Michael , Orzel-Lockwood, Amber O., Kamidani, Satoshi , Pannaraj, Pia S. , Chiotos, Kathleen , Cameron, Melissa A. , Schuster, Jennifer E. , Crandall, Hillary , Kong, Michele , Nofziger, Ryan A. , Staat, Mary Allen , Bhumbra, Samina S. , Irby, Katherine , Boom, Julie A. , Hume, Janet R. , Gertz, Shira J. , Maamari, Mia , Bowens, Cindy , Levy, Emily R. , Bradford, Tamara T. , Walker, Tracie C. , Mack, Elizabeth , Guzman‐Cottrill, Judith A. , Zinter, Matt S. , Bline, Katherine , Randolph, Adrienne G. , Investigators, for the Overcoming COVID-19, Levy, Emily R. , Malloch, Lacy , Simeone, Regina M , Fleming-Dutra, Katherine E , Halasa, Natasha , Wu, Michael , Kamidani, Satoshi , Pannaraj, Pia S , Chiotos, Kathleen , Cameron, Melissa A , Maddux, Aline B , Crandall, Hillary , Kong, Michele , Nofziger, Ryan A , Staat, Mary A , Bhumbra, Samina S , Irby, Katherine , Sahni, Leila C , Hume, Janet R , Gertz, Shira J , Maamari, Mia , Bowens, Cindy , Bradford, Tamara T , Walker, Tracie C , Schwartz, Stephanie P , Mack, Elizabeth H , Guzman-Cottrill, Judith A , Hobbs, Charlotte V , Cvijanovich, Natalie Z , Bline, Katherine E , Hymes, Saul R , Campbell, Angela P , Randolph, Adrienne G , Levy, Emily R , Zambrano, Laura D , Simeone, Regina M. , Maddux, Aline B. , Schwartz, Stephanie P. , Hobbs, Charlotte V. , Hymes, Saul , Investigators, for the Overcoming COVID-19

Mayo Clinic

Pediatric Infectious Disease Journal | December 25, 2023 | Volume: 43 | Issue: 3 | Pages: 242-249

10.1097/inf.0000000000004225 | PMID 38145397 Get It

Background and objectives: In June 2022, the mRNA COVID-19 vaccination was recommended for young children. We examined clinical characteristics and factors associated with vaccination status among vaccine-eligible young children hospitalized for acute COVID-19. Methods: We enrolled inpatients 8 months to <5 years of age with acute community-acquired COVID-19 across 28 US pediatric hospitals from September 20, 2022 to May 31, 2023. We assessed demographic and clinical factors, including the highest level of respiratory support, and vaccination status defined as unvaccinated, incomplete, or complete primary series [at least 2 (Moderna) or 3 (Pfizer-BioNTech) mRNA vaccine doses ≥14 days before hospitalization]. Results: Among 597 children, 174 (29.1%) patients were admitted to the intensive care unit and 75 (12.6%) had a life-threatening illness, including 51 (8.5%) requiring invasive mechanical ventilation. Children with underlying respiratory and neurologic/neuromuscular conditions more frequently received higher respiratory support. Only 4.5% of children hospitalized for COVID-19 (n = 27) had completed their primary COVID-19 vaccination series and 7.0% (n = 42) of children initiated but did not complete their primary series. Among 528 unvaccinated children, nearly half (n = 251) were previously healthy, 3 of them required extracorporeal membrane oxygenation for acute COVID-19 and 1 died. Conclusions: Most young children hospitalized for acute COVID-19, including most children admitted to the intensive care unit and with life-threatening illness, had not initiated COVID-19 vaccination despite being eligible. Nearly half of these children had no underlying conditions. Of the small percentage of children who initiated a COVID-19 primary series, most had not completed it before hospitalization.
Updated Appropriate Use Criteria for Amyloid and Tau PET
Donohoe, Kevin, Herscovitch, Peter, Kuo, Phillip H. , Lingler, Jennifer H. , Price, Julie C. , Salloway, Stephen , Weber, Christopher J., Johnson, Keith A. , Rabinovici, Gil D. , Knopman, David S. , Arbizu, Javier , Benzinger, Tammie L.S. , Hansson, Oskar , Minoshima, Satoshi , Murray, Melissa E. , Carrillo, María C.

Mayo Clinic

Alzheimer's & Dementia | December 25, 2023 | Volume: 19 | Issue: S14 | Pages: No page available

10.1002/alz.078912 Get It

AbstractBackgroundThe Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging convened a Workgroup to update previous Appropriate Use Criteria (AUC) for amyloid PET (Johnson 2013) and develop the first AUC for tau PET. The AUC represent general guidelines and should not be considered a substitute for clinical judgment exercised in the care of individual patients.MethodThe Workgroup included 14 researchers with multidisciplinary expertise. Meetings were held between June 2020 and August 2021. Key research questions were identified using the PICOTS framework, triggering an independent systematic literature review. Using established methods (Fitch 2001), the Workgroup identified 17 clinical scenarios in which amyloid/tau PET may be considered. Appropriateness of amyloid and tau PET as independent, stand‐alone modalities were ranked for each scenario using a 9‐point scale (Table 1). Consensus was achieved using a modified Delphi process. Online surveys were completed iteratively by Workgroup members, followed by discussion, until all votes for each scenario fell within one of the following categories: Appropriate/Uncertain/Rarely Appropriate.ResultAs an over‐arching principle, amyloid/tau PET should be considered in patients who: (1) have undergone a comprehensive assessment by a dementia expert; (2) Alzheimer’s disease (AD) is a diagnostic possibility but uncertainty remains; and (3) knowledge of amyloid/tau PET results is expected to help establish diagnosis and guide patient management. Consensus ratings for clinical scenarios are shown in Table 2. More evidence was available to inform recommendations for amyloid than tau PET. Amyloid PET was considered “Appropriate” to inform diagnosis of MCI or dementia due to suspected AD; clarify diagnosis when CSF biomarkers are equivocal; to inform prognosis in MCI; and to determine eligibility for amyloid‐targeting therapies. Tau PET was considered “Appropriate” to clarify diagnosis in patients with MCI/dementia under age 65 or those with atypical presentations; and to inform prognosis in MCI or dementia due to suspected AD.ConclusionThe updated AUC highlight a growing role for amyloid PET and an emerging role for tau PET in the clinical evaluation of cognitively impaired patients. AUC are expected to further evolve based on data from ongoing studies of clinical utility and a rapidly developing therapeutic landscape.
Risk of 30-Day All-Cause Readmission in Interstitial Lung Disease Patients after COVID-19: National-Level Data
Zadeh, Ali Vaeli , Dinparastisaleh, Roshan , Vaezi, Atefeh , Bandyopadhyay, Debabrata , Rubinstein, Israel , Baig, Hassan , Kawasaki, Takeshi , Magnusson, Jesper , Larsson, Lars-Olof, Herazo‐Maya, Jose D. , Lee, Augustine S. , Mirsaeidi, Mehdi , Baig, Hassan Z, Kawasaki, Takeshi , Mirsaeidi, Mehdi , Candelario, R.A. Calderon , Shahraki, Abdolrazagh Hashemi , Sharafkhaneh, Amir

Mayo Clinic

Annals of the American Thoracic Society | December 22, 2023 | Volume: 21 | Issue: 3 | Pages: 428-437

10.1513/annalsats.202305-491oc | PMID 38134434 Get It

Abstract Rationale Hospital readmission within 30 days poses challenges for healthcare providers, policymakers, and patients because of its impact on care quality, costs, and outcomes. Patients with interstitial lung disease (ILD) are particularly affected by readmission, which is associated with increased morbidity and mortality and reduced quality of life. Because small sample sizes have hindered previous studies, this study seeks to address this gap in knowledge by examining a large-scale dataset. Objective To determine the rate and probability of 30-day all-cause readmission and secondary outcomes in patients with coronavirus disease (COVID-19) or ILD admitted to the hospital. Methods This study is a nested cohort study that used the PearlDiver patient records database. Adult patients (age ⩾18 yr) who were admitted to hospitals in 28 states in the United States with COVID-19 or ILD diagnoses were included. We defined and analyzed two separate cohorts in this study. The first cohort consisted of patients with COVID-19 and was later divided into two groups with or without a history of ILD. The second cohort consisted of patients with ILD and was later divided into groups with COVID-19 or with a non–COVID-19 pneumonia diagnosis at admission. We also studied two other subcohorts of patients with and without idiopathic pulmonary fibrosis within the second cohort. Propensity score matching was employed to match confounders between groups. The Kaplan-Meier log rank test was applied to compare the probabilities of outcomes. Results We assessed the data of 2,286,775 patients with COVID-19 and 118,892 patients with ILD. We found that patients with COVID-19 with preexisting ILD had an odds ratio of 1.6 for 30-day all-cause readmission. Similarly, an odds ratio of 2.42 in readmission rates was observed among hospitalized individuals with ILD who contracted COVID-19 compared with those who were hospitalized for non–COVID-19 pneumonia. Our study also found a significantly higher probability of intensive care admission among patients in both cohorts. Conclusions Patients with ILD face heightened rates of hospital readmissions, particularly when ILD is combined with COVID-19, resulting in adverse outcomes such as decreased quality of life and increased healthcare expenses. It is imperative to prioritize preventive measures against COVID-19 and establish effective postdischarge care strategies for patients with ILD.
Artificial intelligence for triaging of breast cancer screening mammograms and workload reduction: A meta-analysis of a deep learning software
Xavier, Débora Pinheiro , Miyawaki, Isabele, Jorge, Carlos Alberto Campello , Silva, Gabriela Batalini Freitas, Lloyd, Maxwell R. , Batalini, Felipe , Xavier, Debora , Lloyd, Maxwell , Patel, Bhavika , Batalini, Felipe , Miyawaki, Isabele Ayumi , Moraes, Fábio Ynoe de

Mayo Clinic

Journal of Medical Screening | December 20, 2023 | Volume: 31 | Issue: 3 | Pages: 157-165

10.1177/09691413231219952 | PMID 38115810 Get It

Objective Deep learning (DL) has shown promising results for improving mammographic breast cancer diagnosis. However, the impact of artificial intelligence (AI) on the breast cancer screening process has not yet been fully elucidated in terms of potential workload reduction. We aim to assess if AI-based triaging of breast cancer screening mammograms could reduce the radiologist's workload with non-inferior sensitivity. Methods PubMed, EMBASE, Cochrane Central, and Web of Science databases were systematically searched for studies that evaluated AI algorithms on computer-aided triage of breast cancer screening mammograms. We extracted data from homogenous studies and performed a proportion meta-analysis with a random-effects model to examine the radiologist's workload reduction (proportion of low-risk mammograms that could be theoretically ruled out from human's assessment) and the software's sensitivity to breast cancer detection. Results Thirteen studies were selected for full review, and three studies that used the same commercially available DL algorithm were included in the meta-analysis. In the 156,852 examinations included, the threshold of 7 was identified as optimal. With these parameters, radiologist workload decreased by 68.3% (95%CI 0.655–0.711, I² = 98.76%, p < 0.001), while achieving a sensitivity of 93.1% (95%CI 0.882–0.979, I² = 83.86%, p = 0.002) and a specificity of 68.7% (95% CI 0.684–0.723, I² = 97.5%, p < 0.01). Conclusions The deployment of DL computer-aided triage of breast cancer screening mammograms reduces the radiology workload while maintaining high sensitivity. Although the implementation of AI remains complex and heterogeneous, it is a promising tool to optimize healthcare resources.